Orbem

Value proposition

"We make the invisible visible with AI-powered MRI for everything and everyone" [1]

Where it wins

• Non-destructive, industrial-scale MRI that reveals internal biological data (defects, sex, fertility) without damaging the product [1].
• AI-driven analytics that convert raw MRI scans into actionable intelligence for grading, sorting, and health monitoring [1].
• Proven ability to reduce batch losses and extend supply chain transparency across poultry, fruits, and nuts [1].
• Dual-market applicability: immediate revenue in food sustainability with a strategic wedge into human health diagnostics [1].

Credibility: Orbem's homepage details its core technology and impact metrics, confirming the non-destructive nature of the MRI and its application across multiple biological sectors [1].

Business model

• Sells industrial-scale AI-powered MRI systems that scan biological matter non-destructively [1].
• Delivers value through AI analytics that transform hidden internal data into actionable insights [1].
• Scales by deploying hardware across food processing lines and health research facilities [1].
• Margin sits in the software and AI analytics layer, which differentiates from traditional MRI hardware [1].

Competitive landscape

• Traditional MRI providers: Orbem differentiates with AI-driven analytics and non-destructive food applications [1].
• Optical sorting machines: Orbem offers internal defect detection that surface-level optical systems cannot [1].
• Manual inspection methods: Orbem provides faster, more accurate, and scalable grading [1].
• Health diagnostics companies: Orbem's wedge is industrial food MRI, with health as a future expansion [1].

Differentiators: Non-destructive internal scanning, AI-powered actionable insights, and dual-market applicability.

Market pains

• Food industry loses over 1.25 billion tonnes of produce annually due to undetected internal defects [1].
• Poultry producers lack non-invasive methods for sex and fertility determination, impacting breeding efficiency [1].
• Health systems need proactive, preventive monitoring tools to reduce reactive treatment costs [1].
• Supply chains demand radical transparency to meet sustainability and ethical production standards [1].

Strategic implications

Orbem's wedge into food sustainability provides immediate revenue and data, de-risking the pivot to human health diagnostics. The main risk is regulatory approval for health applications, which could delay monetization. The opportunity lies in leveraging food industry scale to subsidize health R&D. The next signal would be a pilot with a major health provider or a patent grant for a health-specific application.

Improvement suggestions

Orbem should prioritize securing regulatory approvals for health applications to unlock the larger market. Developing a freemium model for small food processors could accelerate adoption and data collection. Expanding partnerships with sustainability certification bodies would enhance credibility and drive demand. Investing in user-friendly analytics dashboards would reduce onboarding friction for non-technical customers.